Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease - Wikidata - wikimedia - TriplyDB

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease

http://www.wikidata.org/entity/Q24655078

about

Diabetes mellitus and metformin in hepatocellular carcinoma Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs Metformin and the risk of cancer: time-related biases in observational studies Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects Systematic review: Preventive and therapeutic applications of metformin in liver disease Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study The maternal womb: a novel target for cancer prevention in the era of the obesity pandemic?Metformin exhibits the anti-proliferation and anti-invasion effects in hepatocellular carcinoma cells after insufficient radiofrequency ablation Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients.Cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan.Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.Metformin and breast and gynecological cancer risk among women with diabetes.Insulin resistance and chronic liver disease.Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations.Republished: Non-alcoholic fatty liver disease: a practical approach to treatment.The role of metformin in the management of NAFLD Insulin resistance and metabolic hepatocarcinogenesis with parent-of-origin effects in A×B mice Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis.Effect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the Literature.Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma.Metformin use is associated with better survival of diabetic patients with pancreatic cancer Diabetes and Hepatitis C: A Two-Way Association.Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma.Cancer risk in HBV patients with statin and metformin use: a population-based cohort study.Insulin: potential negative consequences of early routine use in patients with type 2 diabetes.Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis.Insulin resistance and hyperinsulinaemia in the development and progression of cancer.Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway.Metformin as an antitumor agent in cancer prevention and treatment.Metformin: a new option in cancer treatment.Current understanding of insulin resistance in hepatitis C.Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.Does use of metformin protect against cancer in Type 2 diabetes mellitus?Systematic review and meta-analysis of insulin therapy and risk of cancer.

P2860

Q26741205-1180DE81-07DD-4C0E-B859-88C0C27EDC27 Q26750845-11744075-4B1C-4B8F-A279-CF3E9711C681 Q26999266-BD9A5B7A-1A95-426B-B71E-DBDA8E22F4D2 Q28076454-5F6720A3-CCD2-48FE-A5CD-F4C612E22FF2 Q28085535-DC91267C-1FD9-4158-8A7C-14178786BFDA Q28547270-024D34DC-4717-449C-9EAA-D038F9A20130 Q30404178-848717A5-211F-402D-87CD-8F29223B8E1D Q33601115-5281C9B0-4840-4DD0-81DB-EC2F5C7F63F4 Q33672932-76F9F561-5BD8-49B0-8592-CBCE0CF213A7 Q33756122-EAE33F2D-9E15-4E1C-A3EE-29DD09427FF9 Q33795313-9F33811F-408C-4077-B3EA-4E449D3A36E2 Q33812148-D300B5DA-D693-41EC-93C1-556B048F188C Q34008552-2645711E-297F-4969-A911-374429D73026 Q34135248-88B9D211-61F4-47B2-9984-31E60C495064 Q34222524-49B455E1-DA28-489B-B7BF-128880C04EE1 Q34304174-56CFFBE0-0499-48C0-963A-FAA8416A879F Q35046074-4C9DEA2F-101D-454B-9EE2-22B4DB9F7D3A Q35073012-FDACAD0F-912F-4CE4-B86B-48955A2CFB4A Q35104958-7EC72C8F-88D5-4F34-BE77-0A2D57F8F855 Q35135556-4795C8FC-17FD-4319-927B-03D9F2D1CB34 Q35614956-062C41E5-F042-442E-A4A6-2741386276BA Q35679343-B3BE5465-C09A-463E-B91A-B8C32A7A5D6F Q35842470-FB2513B7-DCB2-4FE5-879C-0D0A56AC28EA Q35953756-D4196C26-9E40-42E5-B4F0-E3DA7DEB8ABB Q36051537-D85A7EF9-4B4C-4B38-B5A0-585A68F8820D Q36053323-21FEA6D8-D518-43DE-A4BC-14ECA1501C76 Q36056076-6F187427-2BEF-41EC-BD5D-B8A519F3CFA7 Q36136847-882514BF-9603-4613-A1B2-D5ACBD1E39A9 Q36152361-B055C45E-3D68-4AA4-ACC9-17FD3488EA8C Q36783839-3085E95D-CC47-48A0-B0C7-15AAD55B26F4 Q36788544-43E86E39-E61B-45CA-8C81-26394687896A Q37434345-BA003CAB-8312-42ED-8A0C-44FFE7C51B50 Q37706711-BF74EE81-A901-4C01-AB87-42AF781FF5AE Q37883608-A50C93F2-C647-4007-873E-7F1A3CEFDB87 Q37890687-EEFE3319-4EF0-428D-8BF6-8AED00D24257 Q37903853-BCDC8134-AD91-44C9-8021-4C56BFFE6758 Q37932057-85619196-D24F-4585-B5DC-9178EA56BE88 Q37980432-4B81B342-D46A-4DEB-A97F-1597BAC9CB9E Q38001521-FB825A8C-7CF9-43E4-9118-6E21788FE25E Q38005000-44D42F6D-87E4-4265-AB3C-4870DB3CE226

P2860

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease

http://www.wikidata.org/entity/Q24655078

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Antidiabetic therapy and incre ...... inoma in chronic liver disease

@ast

Antidiabetic therapy and incre ...... inoma in chronic liver disease

@en

Antidiabetic therapy and incre ...... inoma in chronic liver disease

@nl

type

label

Antidiabetic therapy and incre ...... inoma in chronic liver disease

@ast

Antidiabetic therapy and incre ...... inoma in chronic liver disease

@en

Antidiabetic therapy and incre ...... inoma in chronic liver disease

@nl

prefLabel

Antidiabetic therapy and incre ...... inoma in chronic liver disease

@ast

Antidiabetic therapy and incre ...... inoma in chronic liver disease

@en

Antidiabetic therapy and incre ...... inoma in chronic liver disease

@nl

P1433

Q24655078-31E37A06-38E6-46FE-A63C-BC4F9E44C640

P1476

Q24655078-A12E42F9-8CC2-4558-BD34-AC6CFEF0BDCA

P2093

Q24655078-1A2787AE-D4B4-4041-8309-DA2430013994

Q24655078-436D7E1C-7DBF-4D6F-A348-0657649F61F4

Q24655078-4C82A937-92E2-4BF9-AF55-BDBF309D9594

Q24655078-79189678-EC93-49F2-8D7C-756A7DFB335F

Q24655078-940B0661-AD98-462F-BF35-259C23CA5581

Q24655078-9EF6D11D-B7E2-4386-BC1B-3ABB036F788E

Q24655078-A96040E1-148E-426B-878D-FE3C1E110D87

Q24655078-B4C102D6-A574-4792-88B5-F02A43CAACD1

Q24655078-C099F67F-5243-4F37-B5D8-4D5487D44B98

Q24655078-C38EB2B9-31F0-4C66-B738-0F07EF727CE3

P2860

Q24655078-0524D026-5A81-414F-AFB3-9D132298EFD8

Q24655078-1A2E120E-58AF-4398-9581-A50A91540DBC

Q24655078-28673132-2FD9-4B8A-9C8A-9AC86D74E730

Q24655078-2C8E8EBB-C32D-40CD-A4C8-38E1D84C6BFA

Q24655078-4E9C6A81-5D4C-47C1-A168-F6E296848350

Q24655078-5CE73BF5-7E4C-44E5-B64F-BCECEFF6C789

Q24655078-6148FBE1-A442-4A4B-A58C-F8B6E7759F3D

Q24655078-65447A36-1CD6-4C07-A979-FB45ABA71336

Q24655078-674B4DEB-A6FF-4651-B263-52B20D5EF82D

Q24655078-82F15785-1749-4044-8807-1F6FCCB606C0

P304

Q24655078-0AA0967B-6BF4-4A12-A2BC-EF2C2B732254

P31

Q24655078-F672D0E9-6999-41F2-9E93-0775D9BB5F33

P3181

Q24655078-02C311F9-54EF-4371-8794-F858B2DAE24C

P356

Q24655078-742DEC32-96F0-4219-A801-A5BE2986B52F

P407

Q24655078-C779D312-82B9-484A-A3B2-9B5D93887AD4

P433

Q24655078-F4C441BC-EE74-465A-BF9A-D2B8F2CE721F

P478

Q24655078-2D109AFA-2821-4050-A572-E827055471FE

P577

Q24655078-E817F25E-1089-48E8-B75D-C8A022AC0D0F

P5875

Q24655078-704A5BC8-CA7F-4283-AC4B-479AA68F814C

P698

Q24655078-9FA1DB17-47A1-45DF-BDFB-2330A2367546

P932

Q24655078-54011D9F-4AD6-46BB-886D-6FB5706780D2

P3181

P356

P1433

World Journal of Gastroenterology

P1476

Antidiabetic therapy and incre ...... inoma in chronic liver disease

@en

P2093

Antonio Perciaccante

http://www.w3.org/2001/XMLSchema#string

Cesare Miranda

http://www.w3.org/2001/XMLSchema#string

Giorgio Zanette

http://www.w3.org/2001/XMLSchema#string

Giovanni Della Valentina

http://www.w3.org/2001/XMLSchema#string

Maria Dal Mas

http://www.w3.org/2001/XMLSchema#string

Massimiliano Balbi

http://www.w3.org/2001/XMLSchema#string

Michela Ghersetti

http://www.w3.org/2001/XMLSchema#string

Pietro Casarin

http://www.w3.org/2001/XMLSchema#string

Rita Gardenal

http://www.w3.org/2001/XMLSchema#string

Silvia Grazioli

http://www.w3.org/2001/XMLSchema#string

P2860

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

Metformin and reduced risk of cancer in diabetic patients

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.

Report of the expert committee on the diagnosis and classification of diabetes mellitus.

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study.

Hepatocellular carcinoma: present status and future prospects.

Nutrition, insulin, insulin-like growth factors and cancer.

Diabetes and liver disease: an ominous association.

P304

2506-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1802695

http://www.w3.org/2001/XMLSchema#string

P356

10.3748/WJG.15.2506

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26240517

http://www.w3.org/2001/XMLSchema#string

P698

19469001

http://www.w3.org/2001/XMLSchema#string

P932

2686909

http://www.w3.org/2001/XMLSchema#string